-
Bellicum Pharma (BLCM) Prices 8M Share Common Offering at $7.50/Sh
-
Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Bellicum Pharma (BLCM) Announces Proposed 7M Share Common Offering
-
Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Bellicum Pharmaceuticals (BLCM) PT Lowered to $25 at Citi Following Rimiducid Activation Switch
-
Bellicum Pharmaceuticals (BLCM) PT Raised to $27 at Citi
-
Pre-Open Movers 06/29: (STZ) (WATT) (WBA) Higher; (FRED) (RAD) (PIR) Lower (more...)
-
After-Hours Movers 06/28: (GEMP) (PRGS) (NXTD) Higher; (PIR) (BLCM) (DOC) Lower (more...)
-
Bellicum Pharmaceuticals Announces Closing of Public Offering
-
Bellicum Pharma (BLCM) Prices 5M Shares at $12
-
Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Pre-Open Movers 03/23: (HTGM) (SSH) (PVH) (FEYE) Higher; (HTBX) (RARE) (BLCM) Lower (more...)
-
Bellicum Pharma (BLCM) Commences 5M Common Stock Offering
-
Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Citi Upgrades Bellicum Pharmaceuticals (BLCM) to Buy
-
Citi Starts Bellicum Pharmaceuticals (BLCM) at Neutral
-
Citi Starts Bellicum Pharmaceuticals (BLCM) at Buy
-
Pre-Open Stock Movers 01/13: (PCYC) (ELX) (AAPL) Higher; (ECOM) (BGFV) (WWW) Lower (more...)
-
Citi Starts Bellicum Pharmaceuticals (BLCM) at Neutral
-
Bellicum Pharmaceuticals (BLCM) IPO Opens Up 29%
-
Bellicum Pharmaceuticals (BLCM) Prices 7.35M IPO at $19/Share
-
Bellicum Pharmaceuticals (BLCM) Files $115M IPO

